ABOUT NAFTIN® (Naftifine HCl) GEL, 2%
Ask your healthcare provider about once-daily NAFTIN, GEL 2%
When athlete’s foot between the toes won’t go away—even after trying different over-the-counter treatments—it’s time to ask your healthcare provider if a prescription option may be right for you.
Talk to your healthcare provider about prescription NAFTIN Gel, 2%—an FDA-approved antifungal treatment.
Studies show symptoms improve 4 weeks after completing a 2-week treatment with NAFTIN Gel, 2%.
The advantages of a gel
NAFTIN Gel, 2% is water-based. Water-based gels are rapid drying, which is advantageous for treating areas between your toes that tend to stay moist.
NAFTIN Gel, 2% is also non-greasy, which may be preferable in areas covered by socks and shoes.
Apply NAFTIN Gel, 2% directly to the skin (topically) just once a day for 2 weeks.Talk to your doctor
ExpandCollapseClick to See Complete Safety InformationClose
NAFTIN® (Naftifine HCl) Gel, 2%
INDICATIONS AND USAGE: NAFTIN (naftifine hydrochloride) Gel, 2% is an allylamine antifungal indicated for the treatment of athlete’s foot between the toes caused by fungus in patients 12 years of age and older.
WARNING: If there is redness or irritation on the skin with the use of NAFTIN Gel, 2%, stop treatment and speak with your doctor.
INFORMATION FOR PATIENTS:
1. NAFTIN Gel, 2% is only for use on top of the skin. NAFTIN GEL, 2% should not be used in the mouth, eyes, or vagina.
2. If there is irritation or redness with the use of NAFTIN GEL 2%, treatment should be stopped. Contact your doctor if you have irritation or redness on the skin after using NAFTIN Gel, 2%.
Cancer Risk: It is not known whether NAFTIN causes cancer or causes a risk of cancer. Long-term studies to evaluate the risk of cancer from NAFTIN Gel, 2% have not been done.
Pregnancy: Let your doctor know if you are pregnant or plan to become pregnant. NAFTIN Gel, 2% should be used during pregnancy only if the benefit to the mother is greater than the risk to the unborn baby.
Nursing Mothers: It is not known whether this drug passes into breast milk. Because many drugs pass into breast milk, women who are nursing should take care when using NAFTIN Gel, 2%.
Pediatric Use: Safety and effectiveness in children under 12 years old has not been proven.
SIDE EFFECTS: In clinical trials with NAFTIN Gel, 2%, the most common side effect was itching on the skin where the medicine was applied.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit http://www.fda.gov/medwatch or call 1800-FDA-1088.